DRUG PRESCRIPTION AND UTILIZATION IN MORO CCO

Citation
N. Simon et al., DRUG PRESCRIPTION AND UTILIZATION IN MORO CCO, Therapie, 53(2), 1998, pp. 113-120
Citations number
25
Categorie Soggetti
Pharmacology & Pharmacy
Journal title
ISSN journal
00405957
Volume
53
Issue
2
Year of publication
1998
Pages
113 - 120
Database
ISI
SICI code
0040-5957(1998)53:2<113:DPAUIM>2.0.ZU;2-P
Abstract
The aim of this study was to assess drug prescription and utilization in Morocco 8 years after the statement of the Action Program for Essen tial Drugs. To evaluate the role of essential drugs in these prescript ions, a study of about 600 prescriptions and questionnaires sent to a random sample of 111 prescribers and a series of visits with the inves tigator as a neutral observer was undertaken. The average number of dr ugs prescribed was 3.27, which reflected the feelings of most of the c linicians, for whom 3 drugs per patient is the required number. The nu mber of drugs prescribed is lower in the public health structure (2.0 +/- 0.14 depending on the type of institution: hospital or primary hea lth care centre). Specialities from the national list of essential dru gs accounted for 15.48 per cent of all drugs which is to be compared w ith 16.2 per cent of the clinicians stating knowledge of the action pr ogramme for essential drugs. In public structures, these prescriptions ranged between 29.8 per cent and 82.4 per cent of the essential drugs (WHO general list). The length of the visit ranged between 3.27 +/- 0 .96 min and 4.87 +/- 1.04 min according to the health centres and pres criptions included at least one antibiotic in 47.5 per cent of cases ( 25 per cent to 64 per cent). At least one antibiotic was prescribed in 43.3 per cent of cases in the study of prescriptions and 17.3 per cen t of prescriptions included at least one injectable drug. The average cost of one prescription was 146.25 dirhams (ranging between 4 and 120 0 dirhams =US$17). According to 68.6 per cent of the prescribers, the patients felt there to be a strong relation between efficacy and cost. Among the prescription motivations, cost ranked above availability of the drug and after efficacy.